Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

100 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG, Quinn R, Tabet N. Isaac MG, et al. Among authors: tabet n. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002854. doi: 10.1002/14651858.CD002854.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646084 Updated. Review.
Antihypertensives, angiotensin, glucose and Alzheimer's disease.
Nelson L, Tabet N, Richardson C, Gard P. Nelson L, et al. Among authors: tabet n. Expert Rev Neurother. 2013 May;13(5):477-82. doi: 10.1586/ern.13.32. Expert Rev Neurother. 2013. PMID: 23621305 Review.
Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
Farina N, Jernerén F, Turner C, Hart K, Tabet N. Farina N, et al. Among authors: tabet n. Exp Gerontol. 2017 Dec 1;99:146-150. doi: 10.1016/j.exger.2017.10.008. Epub 2017 Oct 10. Exp Gerontol. 2017. PMID: 29024723
Blood pro-inflammatory cytokines in Alzheimer's disease in relation to the use of acetylcholinesterase inhibitors.
Richardson C, Gard PR, Klugman A, Isaac M, Tabet N. Richardson C, et al. Among authors: tabet n. Int J Geriatr Psychiatry. 2013 Dec;28(12):1312-7. doi: 10.1002/gps.3966. Epub 2013 Apr 14. Int J Geriatr Psychiatry. 2013. PMID: 23585364
METHODS: Blood interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha concentrations were assessed using specific enzyme-linked immunosorbent assays in three groups of participants: patients with AD stabilized on a therapeutic dose of an AChEI (n = 42); AChEIs …
METHODS: Blood interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha concentrations were assessed using specific enzyme-linked …
Is Sleep Disruption a Risk Factor for Alzheimer's Disease?
Macedo AC, Balouch S, Tabet N. Macedo AC, et al. Among authors: tabet n. J Alzheimers Dis. 2017;58(4):993-1002. doi: 10.3233/JAD-161287. J Alzheimers Dis. 2017. PMID: 28550253 Review.
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N, Llewellyn D, Isaac MGEKN, Tabet N. Farina N, et al. Among authors: tabet n. Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5. Cochrane Database Syst Rev. 2017. PMID: 28418065 Free PMC article. Review.
MAIN RESULTS: Four trials met the inclusion criteria, but we could only extract outcome data in accordance with our protocol from two trials, one in an AD population (n = 304) and one in an MCI population (n = 516). ...There was no evidence of a difference between v …
MAIN RESULTS: Four trials met the inclusion criteria, but we could only extract outcome data in accordance with our protocol from two trials …
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N, Llewellyn D, Isaac MG, Tabet N. Farina N, et al. Among authors: tabet n. Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4. Cochrane Database Syst Rev. 2017. PMID: 28128435 Free PMC article. Updated. Review.
MAIN RESULTS: Four trials met the inclusion criteria, but we could only extract outcome data in accordance with our protocol from two trials, one in an AD population (n = 304) and one in an MCI population (n = 516). ...There was no evidence of a difference between v …
MAIN RESULTS: Four trials met the inclusion criteria, but we could only extract outcome data in accordance with our protocol from two trials …
100 results
Jump to page
Feedback